Further, to validate that acGM-1.8 directly modulated the phenotype of the macrophages in the tumor, we examined the presence of Ly6C+ cells, together with that of M1 (CD11c+) or M2 (CD206+) cells, in the tumor tissue. This evidence concerns the gene MRC1 and neoplasm.